1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Austria Flow Cytometry Market - Opportunities and Forecast, 2014 - 2020

Flow cytometry is a laser based, biophysical technology that is utilized in the analysis of several physical parameters cells when suspended in a heterogeneous fluid mixture. The flow cytometry technology possesses more precision and accuracy, and lesser time consumption as compared to traditional methods such as ELISA. The flow cytometry technology is utilized across various verticals such as diagnosis of diseases such as cancer, HIV and hematological malignancies, clinical research and academic research activities. The Austria flow cytometry market generated a revenue of $14.0 million in 2014 and expected to garner $27.7 million by 2020, growing at a CAGR of 12.3% during the forecast period. Flow cytometry has emerged as one of the leading technologies due to various technological advancements, extensive usage in the research and its widespread use in the diagnosis and monitoring of various diseases such as cancer, HIV and hematological malignancies. In addition, increasing scope of applications in the fields of drug discovery, microbiology marine biology, and environmental sciences would further drive the market growth. In addition, increasing investments in research and development activities would drive the market growth. The growth of the market is restrained mainly due to high costs and the limited availability of technical expertise. However, further research and development in the fields of drug discovery and diagnostics provide numerous opportunities for the growth of this market. The report analyzes the Austria flow cytometry market on the basis of components, technology, application and end user. Based on components, the market is segmented into instruments, reagents, software and services. On the basis of technology, the market is segmented into bead-based and cell-based technologies. Based on applications, the market is segmented into research application, clinical applications and industrial applications. Based on end users, the market is segmented into commercial organizations, medical schools and clinical testing laboratories, hospitals, academic institutions and others.The report provides a comprehensive overview of the leading companies operating in the Austria market. The key companies profiled in the report include Danaher Corporation, Becton, Dickinson and Co., Merck Millipore, Bio-Rad Laboratories, Inc., and Agilent Technologies, Inc.KEY MARKET BENEFITS:The study provides an in-depth analysis of the Austria flow cytometry market with current and future trends to elucidate the imminent investment pockets in the market.The report provides a quantitative analysis of the current market estimations during the period of 2014-2020 to enable the stakeholders to capitalize on prevailing market opportunities.Extensive analysis of the Austria flow cytometry market based on component helps in understanding the components used in the flow cytometry that are currently used along with the variants that would gain prominence in future.Competitive intelligence of the market highlights the business practices followed by leading market players.Comprehensive analysis of factors that drive and restrict the growth of the Austria flow cytometry market has been provided.SWOT analysis of the market players facilitates the study of the internal environment of the leading companies for strategy formulation.

KEY MARKET SEGMENTS
:The Austria flow cytometry market is segmented as:Market - By Component InstrumentsCytometry platformsSortersAnalyzersReplaceable componentsFilterLaserDetectorsOthers AccessoriesReagents and consumablesAntibodiesDyesBeadsSolutionsBuffersOthersSoftwareServicesMarket - By TechnologyBead based flow cytometryCell based flow cytometryMarket - By ApplicationAcademic and clinical research applicationsCell cycle analysis and cell proliferationApoptosisSorting and screeningTransfection and cell viabilityOthers Diagnosis applicationsOrgan transplantationHaematological malignanciesCancer and solid tumoursImmunodeficiency diseases- HIV infectionOthersMarket - By End usersCommercial organizationsMedical schools and clinical labsHospitalsAcademicsOthers

Table Of Contents

Austria Flow Cytometry Market - Opportunities and Forecast, 2014 - 2020
CHAPTER 1 INTRODUCTION1.1 Report description1.2 Key benefits1.3 Key market segments1.4 Research methodology1.4.1 Secondary research1.4.2 Primary research1.4.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARY2.1 CXO perspectiveCHAPTER 3 MARKET OVERVIEW3.1 Market definition and scope3.2 Key findings3.2.1 Top impacting factors3.2.2 Top winning strategies3.2.3 Top investment pockets3.3 Market share analysis, 20143.4 Government regulations and reimbursement scenario3.5 Market dynamics3.5.1 Drivers3.5.1.1 Technological advancements3.5.1.2 Large scale adoption in research and diagnosis applications3.5.1.3 Increasing applications across novel fields3.5.1.4 Augmented Randamp;D investment3.5.2 Restraints3.5.2.1 High cost of instrument3.5.2.2 Limited technical expertise3.5.3 Opportunities3.5.3.1 Lucrative opportunities in diagnostics in other diseases3.5.3.2 Emerging role of flow cytometry in drug discovery and developmentCHAPTER 4 AUSTRIA FLOW CYTOMETRY MARKET BY COMPONENT4.1 Overview4.1.1 Market size and forecast4.2 Instruments4.2.1 Key market trends4.2.2 Competitive landscape4.2.3 Key growth factors and opportunities4.2.4 Market size and forecast4.2.5 Platforms4.2.5.1 Market size and forecast4.2.5.2 Sorters4.2.5.2.1 MARKET SIZE AND FORECAST4.2.5.3 Analysers4.2.5.3.1 MARKET SIZE AND FORECAST4.2.6 Replaceable components4.2.6.1 Market size and forecast4.2.6.2 Filters4.2.6.2.1 MARKET SIZE AND FORECAST4.2.6.3 Lasers4.2.6.3.1 MARKET SIZE AND FORECAST4.2.6.4 Detectors4.2.6.4.1 MARKET SIZE AND FORECAST4.2.6.5 Others4.2.6.5.1 MARKET SIZE AND FORECAST4.2.7 Accessories4.2.7.1 Market size and forecast4.3 Reagents and consumables4.3.1 Key market trends4.3.2 Competitive landscape4.3.3 Key growth factors and opportunities4.3.4 Market size and forecast4.3.5 Antibodies4.3.5.1 Market size and forecast4.3.6 Dyes4.3.6.1 Market size and forecast4.3.7 Beads4.3.7.1 Market size and forecast4.3.8 Others4.3.8.1 Market size and forecast4.4 Software4.4.1 Key market trends4.4.2 Competitive landscape4.4.3 Key growth factors and opportunities4.4.4 Market size and forecast4.5 Services4.5.1 Key market trends4.5.2 Competitive landscape4.5.3 Key growth factors and opportunities4.5.4 Market size and forecastCHAPTER 5 AUSTRIA FLOW CYTOMETRY MARKET BY TECHNOLOGY5.1 Overview5.1.1 Market size and forecast5.2 Bead-based flow cytometry5.2.1 Key market trends5.2.2 Competitive landscape5.2.3 Key growth factors and opportunities5.3 Cell based flow cytometers5.3.1 Key market trends5.3.2 Competitive landscape5.3.3 Key growth factors and opportunitiesCHAPTER 6 AUSTRIA FLOW CYTOMETRY MARKET BY APPLICATION6.1 Overview6.1.1 Market size and forecast6.2 Research applications6.2.1 Key market trends6.2.2 Competitive landscape6.2.3 Key growth factors and opportunities6.2.4 Market size and forecast6.2.5 Cell cycle analysis and cell proliferation6.2.6 Transfection and cell viability6.3 Clinical applications6.3.1 Key market trends6.3.2 Competitive landscape6.3.1 Key growth factors and opportunities6.3.2 Market size and forecast6.3.3 Apoptosis6.3.4 Sorting/screening6.4 Industrial applications6.4.1 Key market trends6.4.2 Competitive landscape6.4.3 Key growth factors and opportunities6.4.4 Market size and forecast6.4.5 Organ transplantation6.4.6 Hematological malignancies6.4.7 Cancer and Solid Tumour6.4.8 HIV6.4.9 OthersCHAPTER 7 AUSTRIA FLOW CYTOMETRY MARKET BY END USER7.1 Overview7.1.1 Market size and forecast7.2 Commercial organizations7.2.1 Key market trends7.2.2 Key growth factors and opportunities7.3 Medical schools and clinical testing laboratories7.3.1 Key market trends7.3.2 Key growth factors and opportunities7.4 Hospitals7.4.1 Key market trends7.4.2 Key growth factors and opportunities7.5 Academic institutions7.5.1 Key market trends7.5.2 Key growth factors and opportunities7.6 OthersCHAPTER 8 COMPANY PROFILES8.1 Danaher Corporation (Beckman Coulter)8.1.1 Company overview8.1.2 Company snapshot8.1.3 Operating business segments8.1.4 Business performance8.1.5 Key strategic moves and developments8.1.6 SWOT analysis of Danaher Corporation8.2 Becton, Dickinson And Co.8.2.1 Company overview8.2.2 Company snapshot8.2.3 Operating business segments8.2.4 Business performance8.2.5 Key strategic moves and developments8.2.6 SWOT analysis of Becton, Dickinson and Co.8.3 Merck Millipore8.3.1 Company overview8.3.2 Company snapshot8.3.3 Business performance8.3.4 Key strategic moves and developments8.3.5 SWOT analysis of Merck Millipore8.4 Bio-Rad Laboratories, Inc.8.4.1 Company overview8.4.2 Company snapshot8.4.3 Operating business segments8.4.4 Business performance8.4.5 Key strategic moves and developments8.4.6 SWOT analysis of Bio-Rad Laboratories, Inc.8.5 Dako (Agilent Technologies)8.5.1 Company overview8.5.2 Company snapshot8.5.3 Operating business segments8.5.4 Business performance8.5.5 Key strategic moves and developments8.5.6 SWOT analysis of Agilent Technologies, Inc.List of FiguresFIG. 1 TOP IMPACTING FACTORS (2014-2020)FIG. 2 TOP WINNING STRATEGIES PERCENTAGE DISTRIBUTIONFIG. 3 TOP WINNING STRATEGIES BASED ON TYPE AND NATURE OF DEVELOPMENTSFIG. 4 TOP INVESTMENT POCKETSFIG. 5 MARKET SHARE ANALYSIS, 2014FIG. 6 TYPES OF PLATFORMSFIG. 7 ESTIMATED NEW CASES OF CANCER IN AUSTRIA (2014)FIG. 8 NUMBER OF HIV CASES BASED ON LOCATION IN AUSTRIA, 2014FIG. 9 DANAHER CORPORATION, % REVENUE BY BUSINESS SEGMENTS, (2014)FIG. 10 DANAHER CORPORATION, % REVENUE BY GEOGRAPHY (2014)FIG. 11 SWOT ANALYSIS OF DANAHER CORPORATIONFIG. 12 BECTON, DICKINSON AND CO., % REVENUE BY BUSINESS SEGMENTS (2014)FIG. 13 BECTON, DICKINSON AND CO., % REVENUE BY GEOGRAPHY (2014)FIG. 14 SWOT ANALYSIS OF BECTON, DICKINSON AND CO.FIG. 15 MERCK MILLIPORE, % REVENUE BY BUSINESS SEGMENTS (2014)FIG. 16 SWOT ANALYSIS OF MERCK MILLIPOREFIG. 17 BIO-RAD LABORATORIES INC., REVENUE, 2012anddash;2014, ($MILLION)FIG. 18 BIO-RAD LABORATORIES INC., % REVENUES BY BUSINESS UNITS (2014)FIG. 19 BIO-RAD LABORATORIES INC., % REVENUES BY GEOGRAPHY (2014)FIG. 20 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.FIG. 21 AGILENT TECHNOLOGIES INC., %REVENUE BY BUSINESS UNITS, 2014 ($MILLION)FIG. 22 AGILENT TECHNOLOGIES, INC. %REVENUE BY GEOGRAPHY (2014)FIG. 23 SWOT ANALYSIS OF AGILENT TECHNOLOGIES, INC.List of TablesTABLE 1 AUSTRIA FLOW CYTOMETRY MARKET BY COMPONENT 2014-2020 ($THOUSANDS)TABLE 2 AUSTRIA FLOW CYTOMETRY INSTRUMENTS MARKET BY TYPE 2014-2020 ($THOUSANDS)TABLE 3 AUSTRIA FLOW CYTOMETRY PLATFORMS MARKET BY TYPE 2014-2020 ($THOUSANDS)TABLE 4 TYPES OF PLATFORMSTABLE 5 TYPES OF SORTERS:TABLE 6 SORTERS BY KEY PLAYERSTABLE 7 AUSTRIA FLOW CYTOMETRY SORTERS MARKET, 2014-2020 ($THOUSANDS)TABLE 8 ANALYZERS BY KEY PLAYERSTABLE 9 AUSTRIA FLOW CYTOMETRY ANALYZERS MARKET, 2014-2020 ($THOUSANDS)TABLE 10 AUSTRIA FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, 2014-2020 ($THOUSANDS)TABLE 11 TYPES OF FILTERSTABLE 12 AUSTRIA FLOW CYTOMETRY FILTERS MARKET 2014-2020 ($THOUSANDS)TABLE 13 AUSTRIA FLOW CYTOMETRY LASERS MARKET, 2014-2020 ($THOUSANDS)TABLE 14 TYPES OF DETECTORSTABLE 15 AUSTRIA FLOW CYTOMETRY DETECTORS MARKET, 2014-2020 ($THOUSANDS)TABLE 16 AUSTRIA FLOW CYTOMETRY OTHER COMPONENTS MARKET 2014-2020 ($THOUSANDS)TABLE 17 AUSTRIA FLOW CYTOMETRY ACCESSORIES MARKET, 2014-2020 ($THOUSANDS)TABLE 18 AUSTRIA FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET BY PLATFORMS 2014-2020 ($THOUSANDS)TABLE 19 AUSTRIA FLOW CYTOMETRY ANTIBODIES MARKET, 2014-2020 ($THOUSANDS)TABLE 20 AUSTRIA FLOW CYTOMETRY DYES MARKET, 2014-2020 ($THOUSANDS)TABLE 21 AUSTRIA FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY 2014-2020 ($THOUSANDS)TABLE 22 AUSTRIA FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY 2014-2020 ($THOUSANDS)TABLE 23 AUSTRIA FLOW CYTOMETRY- SOFTWARE MARKET, 2014-2020 ($THOUSANDS)TABLE 24 AUSTRIA FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY 2014-2020 ($THOUSANDSS)TABLE 25 AUSTRIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY 2014-2020 ($THOUSANDS)TABLE 26 AUSTRIA FLOW CYTOMETRY MARKET, BY APPLICATIONS 2014-2020 ($THOUSANDS)TABLE 27 AUSTRIA FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS 2014-2020 ($THOUSANDS)TABLE 28 AUSTRIA FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS 2014-2020 ($THOUSANDS)TABLE 29 AUSTRIA FLOW CYTOMETRY MARKET, BY INDUSTRIAL APPLICATIONS 2014-2020 ($THOUSANDS)TABLE 30 AUSTRIA FLOW CYTOMETRY MARKET, BY END USER 2014-2020 ($THOUSANDS)TABLE 31 COMPANY SNAPSHOT OF DANAHER CORPORATIONTABLE 32 DANAHER CORPORATION OPERATING SEGMENTSTABLE 33 COMPANY SNAPSHOT OF BECTON, DICKINSON AND CO.TABLE 34 BECTON, DICKINSON AND COMPANY OPERATING SEGMENTSTABLE 35 SNAPSHOT OF MERCK MILLIPORETABLE 36 COMPANY SNAPSHOT OF BIO-RAD LABORATORIES, INC.TABLE 37 BIO-RAD LABORATORIES, INC. OPERATING SEGMENTSTABLE 38 COMPANY SNAPSHOT OF AGILENT TECHNOLOGIES, INC.TABLE 39 AGILENT TECHNOLOGIES, INC OPERATING SEGMENTS

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.